Pharma Focus Asia
KP - Sustainable Packaging Solutions

Thermo Fisher Opens New Commercial Manufacturing Site in Plainville, USA


Thermo Fisher Scientific Inc., has recently announced its plans to expand its facility for increasing capacity of viral vector development and manufacturing services located at Plainville, Mass, USA.


The project with an investment of $180 million, doubles the size of the company's commercial viral vector capacity to support the rising demand of development and manufacturing of gene therapies and vaccines.

The project is expected to provide around 200 job opportunities.The state-of-the-art facility will have digital connectivity and capabilities to drive operational efficiencies, high quality, data visibility and advanced operator training.

The new site comprises of laboratory and production sites, with warehousing and office space also on-site. The site attracts diverse workforce of scientists, quality control specialists and production teams.

This expansion accelerates the cell and gene therapy innovation, thus giving hope to more patients everywhere.

Construction of the facility is expected to be completed by 2022.


NameThermo Fisher Scientific Inc
Budget$180 million
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024CPHI Chine || PMEC China 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024CPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?